WebMar 1, 2024 · Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2024 Financial Results Read More 02/02/2024 Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences Read More A targeted approach with extraordinary potential Kinases are enzymes that help regulate cellular function. Web2 days ago · DCP Midstream, LP Presentation Alert Email Data Provided by Refinitiv. Minimum 15 minutes delayed. Contact Information DCP Midstream Partners, LP 6900 E. Layton Avenue Suite 900 Denver, CO 80237 Phone: 303-595-3331 Investor Relations Inquiries Madison Spangler Senior Investor Relations Analyst Email: …
Deciphera Pharmaceuticals Announces Pricing of Public Offering …
WebApr 6, 2024 · The Deciphera Pharmaceuticals Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On … WebFind real-time DCPH - Deciphera Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. DCPH - Deciphera Pharmaceuticals Inc Stock quote … goat coat sewing pattern
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2024 …
WebFeb 17, 2024 · The investor relations (IR) department is a division of a business whose job it is to provide investors with an accurate account of company affairs. IR departments are required to be tightly... WebInvestor Relations Deciphera Pharmaceuticals (DCPH) is a biopharmaceutical company focused on discovering, developing, and delivering important new medicines to patients … The Investor Relations website contains information about Deciphera … Investor Relations . Overview; Press Releases; Events and Presentations; … The Investor Relations website contains information about Deciphera … Investor Relations Contact: Argot Partners Investor Relations Maghan Meyers 212 … WebApr 6, 2024 · Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological … bone collector window decal